| 2024 | SCI, SCIE, SSCI, A&HCI
| Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A. Hill, Dimitri P. Mikhailidis and Christos S. Mantzoros | Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies | Pharmacological Reviews |
| 2024 | SCI, SCIE, SSCI, A&HCI
| Muzurović E, Maćešić M, Kavarić S. | Liver Fibrosis and Atherosclerosis, a Consequence of Metabolic Dysfunction-Do They Share a Similar Pathophysiological Background? | Angiology |
| 2024 | SCI, SCIE, SSCI, A&HCI
| Muzurović E, Borozan S, Rizzo, M. | Clinical impact of genetic testing for lipid disorders | Current Opinion in Cardiology |
| 2024 | SCI, SCIE, SSCI, A&HCI
| K Zečević, Š Volčanšek, N Katsiki, M Rizzo, T Miličević Milardović, A Pantea Stoian, M Banach, E Muzurović | Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment | Progress in Cardiovascular Diseases |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Muzurović Emir*, Polyzos Stergios, Mikhailidis Dimitri, Borozan Sanja, Novosel Dušanka, Cmiljanić Oleg, Kadić Nataša and Mantzoros Christos | Non-alcoholic fatty liver disease in children | Current Vascular Pharmacology |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Zečević K, Popović N, Vuksanović Božarić A, Vukmirović M, Rizzo M, Muzurović E | Timing Is Important—Management of Metabolic Syndrome According to the Circadian Rhythm | Biomedicines |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Salmen T, Serbanoiu L-I, Bica I-C, Serafinceanu C, Muzurović E, Janez A, Busnatu S, Banach M, Rizvi AA, Rizzo M, Pantea Stoian A | A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis | IJMS |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Bica I-C, Stoica RA, Salmen T, Janež A, Volčanšek Š, Popovic D, Muzurovic E, Rizzo M, Stoian AP | The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials | Medicina |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Giglio RV, Muzurović EM, Patti AM, Toth PP, Agarwal MA, Almahmeed W, Klisic A, Ciaccio M, Rizzo M | Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? | J Cardiovasc Pharmacol Ther |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Bokan V, Muzurović E, Nejkov S, Rizzo M, Papanas N | Quality of Life in People with Diabetes Mellitus and Unilateral Transtibial Amputation - Aspects of Using the Berg Balance Scale | The International Journal of Lower Extremity Wounds |
| 2023 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Volkan Demirhan Yumuk, Manfredi Rizzo | GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now? | Journal of Diabetes and its Complications |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Milena Cojić, Zoja Stanković and Andrej Janež | Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease | Current Vascular Pharmacology |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Muzurović, E., Tomšić, K.Z., Vujošević, S. and Petakov, M. | Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism | Hormones |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Nahum Méndez-Sánchez, Elisabetta Bugianesi, Robert G Gish, Frank Lammert, Herbert Tilg, Mindie H Nguyen, Shiv K Sarin, Núria Fabrellas, Shira Zelber-Sagi, Jian-Gao Fan, Gamal Shiha, Giovanni Targher, Ming-Hua Zheng, Wah-Kheong Chan, Shlomo Vinker, Takumi Kawaguchi, Laurent Castera, Yusuf Yilmaz, Marko Korenjak, C Wendy Spearman, Mehmet Ungan, Melissa Palmer, Mortada El-Shabrawi, Hans-Juergen Gruss, Jean-François Dufour, Anil Dhawan, Heiner Wedemeyer, Jacob George, Luca Valenti, Yasser Fouad, Manuel Romero-Gomez , Mohammed Eslam , Global multi-stakeholder consensus on the redefinition of fatty liver disease | Global multi-stakeholder endorsement of the MAFLD definition | Lancet Gastroenterol Hepatol |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Muzurović E, Peng CC, Belanger MJ, Sanoudou D, Mikhailidis DP, Mantzoros C. | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. | Hypertension |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Janez A, Muzurovic E, Stoian AP, Haluzik M, Guja C, Czupryniak L, Duvnjak L, Lalic N, Tankova T, Bogdanski P, Papanas N, Nunes JS, Kempler P, Fras Z, Rizzo M | Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group | Int J Cardiol |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Muzurović E, Borozan S, Vujošević S, Gurnell M | Thyroid status and vascular risk: an update | Curr Vasc Pharmacol |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Muzurović E, Rizzo M, Mikhailidis DP | Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients | J Diabetes Complications |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Muzurović EM, Volčanšek Š, Tomšić KZ, Janež A, Mikhailidis DP, Rizzo M, Mantzoros CS | Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence | J Cardiovasc Pharmacol Ther |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Emir M Muzurović, Dimitri P Mikhailidis | Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease-Pathogenesis and Pharmacological Treatment Options | J Cardiovasc Pharmacol Ther |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Darko Kastelan, Emir Muzurovic, Tina Dusek | Approach to patients with European Network for the Study of Adrenal Tumor stages I and II adrenocortical carcinomas | Curr Opin Endocrinol Diabetes Obes |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Aart J van der Lely, Mark Gurnell | AST to ALT Ratio and Peripheral Arterial Disease in a Hypertensive Population-Is There a Link? | Angiology |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Emir M Muzurović, Snežana Vujošević, Dimitri P Mikhailidis | Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes? | J Cardiovasc Pharmacol Ther |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Dimitri P Mikhailidis, Christos Mantzoros | Non-Alcoholic Fatty Liver Disease, Insulin Resistance, Metabolic Syndrome and their Association with Vascular Risk | Metabolism |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Brigita Smolović, Mirjana Miladinović, Damir Muhović, Branko Čampar | Diagnosis and treatment of mediastinal ectopic thyroid tissue with normally located thyroid gland and primary hyperparathyroidism: a case report | Gland Surgery |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Emir M Muzurović, Sanja Borozan | Re: Iglay K, Hannachi H, Engel SS, et al. Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis. Curr Med Res Opin. 2021. DOI:10.1080/03007995.2021.1895736 | Curr Med Res Opin |
| 2021 | SCOPUS
| Emir Muzurović, Sanja Medenica, Milovan Kalezić, Siniša Pavlović | Primary hyperparathyroidism associated with acquired long QT interval and ventricular tachycardia | Endocrinol Diabetes Metab Case Rep |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Siniša Dragnić, Sanja Medenica, Brigita Smolović, Predrag Bulajić, Dimitri P Mikhailidis | Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease prevention | J Diabetes Complications |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Dimitri P Mikhailidis, Christos Mantzoros | Commentary: From mice to men: In search for dietary interventions to form the background on which pharmacotherapy for non-alcoholic fatty liver disease should be based | Metabolism |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Dimitri P Mikhailidis | Impact of glucagon-like peptide 1 receptor agonists and sodium-glucose transport protein 2 inhibitors on blood pressure and lipid profile | Expert opinion on pharmacotherapy |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Brigita Smolović, Snežana Vujošević, Milan Petakov | Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role? | Curr Vasc Pharmacol |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Zoja Stanković, Zlata Kovačević, Benida Šahmanović Škrijelj, Dimitri P Mikhailidis | Inflammatory Markers Associated With Diabetes Mellitus - Old and New Players | Curr Pharm Des |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Emir Muzurović, Ivana Kraljević, Mirsala Solak, Siniša Dragnić, Dimitri P Mikhailidis | Homocysteine and diabetes: Role in macrovascular and microvascular complications | J Diabetes Complications |
| 2016 | SCOPUS
| EMIR MUZUROVIĆ, SNEŽANA VUJOŠEVIĆ, MARINA RATKOVIĆ , DANILO RADUNOVIĆ and DRAGICA BOŽOVIĆ | THE IMPACT OF SECONDARY HYPERPARATHYROIDISM ON ECHOCARDIOGRAPHIC PARAMETERS IN HEMODIALYSIS PATIENTS | Acta Med Croatica |
